MicroRNA control of podosome formation in vascular smooth muscle cells in vivo and in vitro

被引:185
作者
Quintavalle, Manuela [2 ]
Elia, Leonardo [1 ,3 ,4 ]
Condorelli, Gianluigi [1 ,3 ,4 ]
Courtneidge, Sara A. [2 ]
机构
[1] Univ Calif San Diego, Sch Med, Div Cardiol, La Jolla, CA 92093 USA
[2] Sanford Burnham Inst Med Res, La Jolla, CA 92037 USA
[3] CNR, Inst Biomed Technol, I-20138 Milan, Italy
[4] MultiMed Hosp, Ist Ricovero & Cura Carattere Sci, I-20138 Milan, Italy
基金
美国国家卫生研究院;
关键词
SRC FAMILY KINASES; GROWTH-FACTOR; SIGNAL-TRANSDUCTION; TYROSINE KINASES; GENE-EXPRESSION; PROTEIN; CANCER; DIFFERENTIATION; ASSOCIATION; INVADOPODIA;
D O I
10.1083/jcb.200912096
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Smooth muscle cell (SMC) plasticity plays an important role during development and in vascular pathologies such as atherosclerosis and restenosis. It was recently shown that down-regulation of microRNA (miR)-143 and -145, which are coexpressed from a single promoter, regulates the switch from contractile to synthetic phenotype, allowing SMCs to migrate and proliferate. We show in this study that loss of miR-143/145 in vitro and in vivo results in the formation of podosomes, which are actin-rich membrane protrusions involved in the migration of several cell types, including SMCs. We further show that platelet-derived growth factor (PDGF) mediates podosome formation in SMCs through the regulation of miR-143/145 expression via a pathway involving Src and p53. Moreover, we identify key podosome regulators as targets of miR-143 (PDGF receptor. and protein kinase C.) and miR-145 (fascin). Thus, dysregulation of the miR-143 and -145 genes is causally involved in the aberrant SMC plasticity encountered during vascular disease, in part through the up-regulation of an autoregulatory loop that promotes podosome formation.
引用
收藏
页码:13 / 22
页数:10
相关论文
共 45 条
[1]   Roles of fascin in cell adhesion and motility [J].
Adams, JC .
CURRENT OPINION IN CELL BIOLOGY, 2004, 16 (05) :590-596
[2]   Downregulation of microRNAs-143 and-145 in B-cell malignancies [J].
Akao, Yukihiro ;
Nakagawa, Yoshihito ;
Kitade, Yukio ;
Kinoshita, Tomohiro ;
Naoe, Tomoki .
CANCER SCIENCE, 2007, 98 (12) :1914-1920
[3]   Biology of platelet-derived growth factor and its involvement in disease [J].
Alvarez, Ricardo H. ;
Kantarjian, Hagop M. ;
Cortes, Jorge E. .
MAYO CLINIC PROCEEDINGS, 2006, 81 (09) :1241-1257
[4]   Role of platelet-derived growth factors in physiology and medicine [J].
Andrae, Johanna ;
Gallini, Radiosa ;
Betsholtz, Christer .
GENES & DEVELOPMENT, 2008, 22 (10) :1276-1312
[5]   PLATELET-DERIVED GROWTH-FACTOR GENE-EXPRESSION IN HUMAN ATHEROSCLEROTIC PLAQUES AND NORMAL ARTERY WALL [J].
BARRETT, TB ;
BENDITT, EP .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1988, 85 (08) :2810-2814
[6]   MicroRNAs: Genomics, biogenesis, mechanism, and function (Reprinted from Cell, vol 116, pg 281-297, 2004) [J].
Bartel, David P. .
CELL, 2007, 131 (04) :11-29
[7]   Active Rho is localized to podosomes induced by oncogenic Src and is required for their assembly and function [J].
Berdeaux, RL ;
Díaz, B ;
Kim, L ;
Martin, GS .
JOURNAL OF CELL BIOLOGY, 2004, 166 (03) :317-323
[8]   SU6656, a selective Src family kinase inhibitor, used to probe growth factor signaling [J].
Blake, RA ;
Broome, MA ;
Liu, XD ;
Wu, JM ;
Gishizky, M ;
Sun, L ;
Courtneidge, SA .
MOLECULAR AND CELLULAR BIOLOGY, 2000, 20 (23) :9018-9027
[9]   Acquisition of the contractile phenotype by murine arterial smooth muscle cells depends on the Mir143/145 gene cluster [J].
Boettger, Thomas ;
Beetz, Nadine ;
Kostin, Sawa ;
Schneider, Johanna ;
Krueger, Marcus ;
Hein, Lutz ;
Braun, Thomas .
JOURNAL OF CLINICAL INVESTIGATION, 2009, 119 (09) :2634-2647
[10]   Protein kinase C family: On the crossroads of cell signaling in skin and tumor epithelium [J].
Breitkreutz, D. ;
Braiman-Wiksman, L. ;
Daum, N. ;
Denning, M. F. ;
Tennenbaum, T. .
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2007, 133 (11) :793-808